Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort StudyAlexis Tabah, Jean‐François Timsit, Despoina Koulenti et al.|Intensive Care Medicine|2012Cited by 449
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Jan J. De Waele, Sofie Carrette et al.|Critical Care|2013Cited by 212
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trialJan J. De Waele, Alain Verstraete, Sofie Carrette et al.|Intensive Care Medicine|2013Cited by 190
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)Alexis Tabah, José Garnacho‐Montero, Matteo Bassetti et al.|Intensive Care Medicine|2019Cited by 185
Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICUJan Gunst, Greet Van den Berghe, Yves Debaveye et al.|New England Journal of Medicine|2023Cited by 149